Twist Bioscience (TWST) reported a fiscal Q1 loss Monday of $0.53 per diluted share, narrower than a loss of $0.75 a year earlier.
Analysts polled by FactSet expected a loss of $0.68.
Revenue for the quarter ended Dec. 31 was $88.7 million, compared with $71.5 million a year earlier.
Analysts surveyed by FactSet expected $87 million.
The company said it expects fiscal Q2 revenue of $91 million to $93 million.
Analysts polled by FactSet expect $90.9 million.
For fiscal 2025, Twist Bioscience raised its revenue guidance to $372 million to $379 million, compared with its previous guidance range of $367 million to $377 million.
Analysts polled by FactSet expect 373.3 million.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。